Cite
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats
MLA
Qian Zhang, et al. “Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuated Endothelial Dysfunction through MiRNAs in Diabetic Rats.” Archives of Medical Science, vol. 17, no. 5, July 2019, pp. 1378–87. EBSCOhost, https://doi.org/10.5114/aoms.2019.86609.
APA
Qian Zhang, Xinhua Xiao, Jia Zheng, Ming Li, Miao Yu, Fan Ping, Tong Wang, & Xiaojing Wang. (2019). Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats. Archives of Medical Science, 17(5), 1378–1387. https://doi.org/10.5114/aoms.2019.86609
Chicago
Qian Zhang, Xinhua Xiao, Jia Zheng, Ming Li, Miao Yu, Fan Ping, Tong Wang, and Xiaojing Wang. 2019. “Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuated Endothelial Dysfunction through MiRNAs in Diabetic Rats.” Archives of Medical Science 17 (5): 1378–87. doi:10.5114/aoms.2019.86609.